| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.008 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.009 |